Related references
Note: Only part of the references are listed.Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
Dongli Cai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Associations of B7-H3 and B7-H4 Expression in Ductal Carcinoma In Situ of the Breast With Clinicopathologic Features and T-Cell Infiltration
Nah Ihm Kim et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2020)
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC)
Daniel Carvajal-Hausdorf et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
Dean Nehama et al.
EBIOMEDICINE (2019)
Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups
Lawrence P. Andrews et al.
NATURE IMMUNOLOGY (2019)
B7-H3 expression and its correlation with clinicopathologic features, angiogenesis, and prognosis in intrahepatic cholangiocarcinoma
Rui Cheng et al.
APMIS (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
Kentaro Inamura et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma
Chaoqi Zhang et al.
ONCOIMMUNOLOGY (2018)
Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis
Zhicheng Zeng et al.
NATURE COMMUNICATIONS (2018)
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis
B. Benzon et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2017)
Leveraging the immune system to treat advanced thyroid cancers
Jena D. French et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy
Elodie Picarda et al.
CLINICAL CANCER RESEARCH (2016)
B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes
Christina Tekle et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression
Hexing Yuan et al.
JOURNAL OF UROLOGY (2011)
Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma
Paul L. Crispen et al.
CLINICAL CANCER RESEARCH (2008)
Genes that distinguish physiological and pathological angiogenesis
Steven Seaman et al.
CANCER CELL (2007)
B7-H3 and B7-H4 expression in non-small-cell lung cancer
Yuping Sun et al.
LUNG CANCER (2006)
The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses
WK Suh et al.
NATURE IMMUNOLOGY (2003)
Share Paper
